BioSpace News Archive

Trevi Therapeutics, Inc. today announced senior management will attend and participate in the following events in September.

A new physician-training system in telehealth simulates key parts of traditional, in-person neurological exams that use little reflex hammers, pinpricks, and flashlights to test nerve function.

Redwire Corporation, a leader in space infrastructure for the next generation space economy, announced that Redwire Chairman and Chief Executive Officer Peter Cannito and Chief Financial Officer Jonathan Baliff will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference.

Aptose Biosciences Inc. announced closing of a $3 million investment in common shares of the Company as the first tranche of a private equity investment for up to a maximum of $7 million or 19.99 percent ownership interest by Hanmi Pharmaceutical, Inc., Seoul, South Korea.

QurAlis today announced it will present preclinical data showing that TDP-43 (TAR DNA-binding protein 43) pathology drives loss of synaptic UNC13A function in neurodegenerative diseases including ALS and frontotemporal dementia (FTD).

Apnimed announced that a post-hoc analysis of data from the MARIPOSA Phase 2b trial, an efficacy, safety and dose-finding study for AD109 (aroxybutynin/atomoxetine) of one-month duration, will be featured at a poster presentation at the European Respiratory Society’s (ERS) International Congress 2023 in Milan, Italy.

Lyra Therapeutics , Inc. today announced that Maria Palasis, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences in September.

MaxCyte, Inc. today announced the appointment of Ali Soleymannezhad as Executive Vice President of Bioprocessing, effective August 21, 2023.

Elicio Therapeutics, Inc. today announced that Robert Connelly, Chief Executive Officer, will present at the upcoming H.C. Wainwright 25th Annual Global Investment Conference on September 13, 2023 at 9:30 a.m. ET.

Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference.